[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368930-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368930-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","profile-of-biological-aging-in-first-primary-cancers-a-pan-cancer-analysis-of-two-large-scale-cohorts-from-the-uk-and-hong-kong","Profile of biological aging in first primary cancers - a pan-cancer analysis of two large-scale cohorts from the UK and Hong Kong","","A pan-cancer investigation characterizes biological aging profiles in first primary cancer types across UK and Hong Kong populations and tests how aging relates bidirectionally to genetic risk. Using 414,599 UK Biobank participants and 83,788 Hong Kong Hospital Authority EHR participants, multivariable Cox and logistic models link BioAgeAccel to cancer incidence and mortality. Cancer-specific PRS and population attributable fractions quantify aging versus genetics, while nested bidirectional Mendelian randomization estimates reciprocal causality, highlighting lung, prostate, and female breast cancer patterns.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/profile-of-biological-aging-in-first-primary-cancers-a-pan-cancer-analysis-of-two-large-scale-cohorts-from-the-uk-and-hong-kong/368930/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/profile-of-biological-aging-in-first-primary-cancers-a-pan-cancer-analysis-of-two-large-scale-cohorts-from-the-uk-and-hong-kong/368930.png","ImageObject",300,407,{"name":42,"@type":43},"Guten tag","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",18,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this pan-cancer study?","Question",{"text":63,"@type":64},"To describe biological aging profiles across specific cancer types in diverse populations and to examine the bidirectional relationship between aging and cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which datasets are used to assess biological age acceleration and cancer outcomes?",{"text":68,"@type":64},"The study uses 414,599 participants from UK Biobank and 83,788 participants from Hong Kong Hospital Authority electronic health records.",{"name":70,"@type":61,"acceptedAnswer":71},"What methods are used to study the link between biological aging and cancer?",{"text":72,"@type":64},"Multivariable Cox and logistic regression models evaluate associations between BioAgeAccel and site-specific cancers, and nested bidirectional Mendelian randomization assesses reciprocal causality.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368930,1790216710,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Zhan et al. BMC Medicine (2025) 23:570 [https://doi.org/10.1186/s12916-025-04409-z](https://doi.org/10.1186/s12916-025-04409-z)  \nBMC Medicine  \n RESEARCH Open Access  \nProfile of biological aging in first primary  \ncancers: a pan-cancer analysis of two large-scale cohorts from the UK and Hong Kong  \nYongle Zhan1,2†, Ruofan Shi1,3†, Xiaohao Ruan3, Chi Yao1, TsunTsun Stacia Chun1, Jiacheng Liu3, Salida Ali1, Ruochen Ma1, Da Huang3, Jingyi Huang3, Adrian Chun Yin Lam4, Ada Tsui-Lin Ng5, Weiguo Hu6* and Rong Na 1,5*  \nAbstract  \nBackground Aging is a major risk factor for cancer, but the landscape of biological aging across different cancer types and its interplay with genetic risk remains unclear. This study aims to depict the biological aging profiles in specific cancers across diverse populations and investigate the bidirectional relationship between aging and cancer. Methods This study included 414,599 participants from the UK Biobank (UKB) and 83,788 participants from the electronic health record database of Hong Kong Hospital Authority (EHR-HK) . Multivariable Cox and logistic regression models were used to evaluate associations between biological age acceleration (BioAgeAccel) and site-specific cancers in the UKB and EHR-HK, respectively. In the UKB cohort (n= 387,066), we further computed cancer-specific polygenic risk scores (PRSs) and calculated population attributable fractions (PAFs) to quantify the relative contributions of aging and genetics to cancer incidence and mortality. A nested two-sample bidirectional Mendelian randomization (MR) analysis within one-sample setting was employed to explore the reciprocal causality between aging and cancer. Results Compared to cancer-free individuals, the most pronounced BioAgeAccel disparities were observed in liver cancer (mean difference (MD): 5.9 years) within the UKB, and oesophageal cancer (MD = 18.4 years) within the EHR-HK. A 5-year increment in BioAgeAccel was associated with elevated overall cancer risk, with leukaemia demonstrating the highest hazard ratio in the UKB (HR = 1 . 13, 95% CI: 1.11–1. 15) and oesophageal cancer exhibiting the highest odds ratio in the EHR-HK (OR = 1 . 55, 95% CI: 1.33–1. 81) . PAF analyses revealed that BioAgeAccel contributed to 47% of lung cancer incidence and 60% of lung cancer-specific mortality, exceeding contributions from genetic risk. Significant interactions between genetics and aging were identified for colorectal, lung and non-melanoma skin cancer. Bidirectional MR analyses demonstrated the reciprocal relationship between BioAgeAccel and lung cancer (aging-to-cancer nexus: OR = 1 . 30, 95% CI: 1.11–1. 51; cancer-to-aging nexus: 1.05 (1 .02–1. 08)), female breast cancer (aging-to-cancer nexus: 1.09 (1 .02–1. 15); cancer-to-aging nexus: 1.05 (1 .03–1. 07)), and prostate cancer (aging-to-cancer nexus: 1.08 (1 .01–1. 16); cancer-to-aging nexus: 1.02 (1 .00–1. 03)) .  \n†Yongle Zhan and Ruofan Shi contribute equally to this work.  \n*Correspondence: Weiguo Hu [wghu@rjh.com.cn](wghu@rjh.com.cn)[ ](wghu@rjh.com.cn)Rong Na  \n[narong.hs@gmail.com](narong.hs@gmail.com); yungna@hku. hk  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and ","cbCaiqhTf0OHbG6t","https://ap.wps.com/l/cbCaiqhTf0OHbG6t","pdf",1340532,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n## Keywords","[{\"question\":\"What is the main goal of this pan-cancer study?\",\"answer\":\"To describe biological aging profiles across specific cancer types in diverse populations and to examine the bidirectional relationship between aging and cancer.\"},{\"question\":\"Which datasets are used to assess biological age acceleration and cancer outcomes?\",\"answer\":\"The study uses 414,599 participants from UK Biobank and 83,788 participants from Hong Kong Hospital Authority electronic health records.\"},{\"question\":\"What methods are used to study the link between biological aging and cancer?\",\"answer\":\"Multivariable Cox and logistic regression models evaluate associations between BioAgeAccel and site-specific cancers, and nested bidirectional Mendelian randomization assesses reciprocal causality.\"}]","Profile of biological aging in first primary cancers - a pan-cancer analysis of two large-scale cohorts from the UK and Hong Kong | PDF",1790179256,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58697dfc84e397b5e6d39f7009d1262c.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90525b5f70b21002c870185c66c87dd8.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae573d04081a69e038b75b8c1ec43347.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71b54ac59e2a7ac24fbf8aef12e3baad.webp",980,1301]